Vaxxinity

Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health, with a focus on developing peptide-based therapeutic vaccines for chronic diseases including Alzheimer's, Parkinson's, and COVID-19. Formed in 2021 through the combination of COVAXX and United Neuroscience, the company is headquartered in Dallas, Texas, and uses an immune-system-based approach to deliver vaccines that are cost-effective, long-lasting, and effective against emerging variants without requiring cold-chain mRNA technology. Vaxxinity's mission is to make high-quality biologic medicines accessible to people around the world by replacing expensive injectable biologics with affordable vaccine alternatives.